ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      60,153.90
      1.55%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lexicon Pharmaceuticals Inc (LXRX)

      7. Lexicon Pharmaceuticals Inc (LXRX) News

      LXRX

      Lexicon Pharmaceuticals (LXRX)

      Lexicon Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LXRX
      DateTimeSourceHeadlineSymbolCompany
      11/29/20189:00AMGlobeNewswire Inc.FDA Advisory Committee to Review Investigational Sotagliflozin as Potential Treatment for Type 1 DiabetesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/08/20184:00PMGlobeNewswire Inc.Lexicon Pharmaceuticals to Present at Upcoming Investor ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/06/20187:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Present at Upcoming Investor ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/01/20185:20PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/01/20187:18AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/01/20187:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides a Business UpdateNASDAQ:LXRXLexicon Pharmaceuticals Inc
      10/25/20187:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Host Third Quarter 2018 Financial Results Conference Call and Webcast on November 1, 2018NASDAQ:LXRXLexicon Pharmaceuticals Inc
      10/16/20188:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals and Ipsen Biopharmaceuticals Canada Inc. Announce Health Canada Approval of XERMELO® (Telotristat Et...NASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/24/20187:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Present Sotagliflozin Clinical Data at the European Association for the Study of Diabetes 54th Ann...NASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/24/20187:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Present at Upcoming Investor ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/04/20185:19PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/30/20187:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Present at Upcoming Investor ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/22/20184:22PMGlobeNewswire Inc.UPDATE: Lexicon Pharmaceuticals to Present at Upcoming Investor ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/22/20184:00PMGlobeNewswire Inc.Lexicon Pharmaceuticals to Present at Upcoming Investor ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/31/20184:00PMGlobeNewswire Inc.Lexicon Pharmaceuticals to Present at Upcoming Investor ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/30/20184:58PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/30/20187:10AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/30/20187:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides a Business UpdateNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/26/20189:00AMPR Newswire (US)New Insights Revealed in National Survey Show More Advances Are Needed for the Type 1 Diabetes CommunityNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/23/20184:46PMGlobeNewswire Inc.UPDATE - Lexicon Pharmaceuticals to Host Second Quarter 2018 Financial Results Conference Call and Webcast on July 30, 2018NASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/23/20184:01PMGlobeNewswire Inc.Lexicon Pharmaceuticals to Host First Quarter 2018 Financial Results Conference Call and Webcast on July 30, 2018NASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/29/20184:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/29/20184:10PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/26/20185:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/24/20184:01PMGlobeNewswire Inc.Lexicon Pharmaceuticals Announces Positive 52-Week Results From Sotagliflozin inTandem1 Study Presented at ADA 2018 and Publi...NASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/23/20181:30PMGlobeNewswire Inc.Lexicon Pharmaceuticals Announces Positive 52-Week Results From Sotagliflozin inTandem2 Study Presented at ADA 2018 and Publi...NASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/21/20185:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/18/20186:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/18/20187:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Present New Clinical Data at 78th American Diabetes Association Scientific SessionsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/12/20186:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:LXRX